Rapid Screening for Entry Inhibitors of Highly Pathogenic Viruses under Low-Level Biocontainment

• Aparna Talekar,

  Affiliation Departments of Pediatrics, Microbiology and Immunology, Weill Medical College, Cornell University, New York, New York, United States of America

  ⨯
• Antonello Pessi,

  Affiliation PeptiPharma, Pomezia, Italy

  ⨯
• Fraser Glickman,

  Affiliation High Throughput Screening Resource Center, The Rockefeller University, New York, New York, United States of America

  ⨯
• Uttara Sengupta,

  Affiliation Departments of Pediatrics, Microbiology and Immunology, Weill Medical College, Cornell University, New York, New York, United States of America

  ⨯
• Thomas Briese,

  Affiliation Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, United States of America

  ⨯
• Michael A. Whitt,

  Affiliation Department of Microbiology, Immunology and Biochemistry, Health Science Center, The University of Tennessee, Memphis, Tennessee, United States of America

  ⨯
• Cyrille Mathieu,

  Affiliation INSERM, U758, Ecole Normale Supérieure de Lyon, Lyon, France

  ⨯
• Branka Horvat,

  Affiliations INSERM, U758, Ecole Normale Supérieure de Lyon, Lyon, France, IFR128 BioSciences Lyon-Gerland Lyon-Sud, University of Lyon 1, Lyon, France

  ⨯
• Anne Moscona,

  Affiliation Departments of Pediatrics, Microbiology and Immunology, Weill Medical College, Cornell University, New York, New York, United States of America

  ⨯
• Matteo Porotto

  * E-mail: map2028@med.cornell.edu

  Affiliation Departments of Pediatrics, Microbiology and Immunology, Weill Medical College, Cornell University, New York, New York, United States of America

  ⨯